Clinical Trial Update: Photosensitization Study in Androgenetic Alopecia [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating a photosensitization approach for androgenetic alopecia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Androgenetic Alopecia

Snippet

Sponsor: Polichem S.A. | Conditions: Androgenetic Alopecia | Phase 1 | Status: COMPLETED